Healthcare News
 Updated 3 times daily.
 Select a news topic:
Music On Prescription Could Help Treat Emotional And Physical Pain Fri, 10 Sep 2010
New research into how music conveys emotion could benefit the treatment of depression and the management of physical pain. Using an innovative combination of music psychology and leading-edge audio engineering the project is looking in more detail than ever before at how music conveys emotion...
OpEds: Health Costs And New Law; Penn. Doctor Supply; Anesthesiologists Vs. Nurses Wed, 08 Sep 2010
Healthcare Reforms Don't Go Far Enough The Los Angeles TimesSome sort of Medicare-for-all program remains the only equitable way that every American can be provided with adequate and affordable coverage. This wouldn't be socialized medicine and it wouldn't be state-run healthcare (David Lazarus, 9/7). Despite Reform, Health Costs Are Still On The Rise The (Wilmington, Del...
Researchers Identify New Therapeutic Target To Improve Pain Management After Chronic Morphine Administration Wed, 08 Sep 2010
Researchers from Mount Sinai School of Medicine have discovered a major mechanism underlying the development of tolerance to chronic morphine treatment. The discovery may help researchers find new therapies to treat chronic pain, and reduce tolerance and side effects associated with morphine use. The findings are published in the July 20th issue of Science Signaling...
Treatment Of Pain To Feature At PAC10, Australia Tue, 07 Sep 2010
The management of persistent pain requires a different approach to that of acute pain. Whereas the initial problem can be addressed with acute pain, persistent pain requires restoration of physical, psychological and social function with minimisation of distress, decreasing the pain to a tolerable level rather than a cure and addressing the whole person in the rehabilitative process...
Ask Questions, Save Lives; Risk Assessment Of Children's Respiratory Systems Identifies Potential Anesthetic Complications Mon, 06 Sep 2010
It is fairly easy to avoid surgical complications in children related to anesthesia administration by asking a few simple questions before arriving at the operating table...
Relaxed Attitude Towards Medicines Leading To Greater Health Problems, Australia Mon, 06 Sep 2010
Australians' blasé attitude towards medicines is leading to further health problems for many people and is placing avoidable pressure on our health system...
Codeine-Ibuprofen Misuse Results In Serious Morbidity, Australia Mon, 06 Sep 2010
Although codeine-ibuprofen can be considered a relatively weak opioid analgesic, it is nevertheless addictive and more research is needed to develop health care responses to its misuse, according to an article in the Medical Journal of Australia...
Molecules Involved In Touch And Other Mechanically Activated Systems Identified Mon, 06 Sep 2010
Scripps Research Institute scientists have identified two proteins with potential to be important targets for research into a wide range of health problems, including pain, deafness, and cardiac and kidney dysfunction. The study was published in Science Express, the advanced, online edition of the journal Science...
BioDelivery Sciences Announces Positive Meeting With FDA On A Streamlined ONSOLIS REMS With Broadened Distribution Sun, 05 Sep 2010
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced a positive meeting with the U.S. Food and Drug Administration (FDA), Meda and BDSI that occurred on Wednesday, July 21, 2010 to discuss significant modifications to the existing Risk Evaluation and Mitigation Strategy (REMS) program for ONSOLIS (fentanyl buccal soluble film)...
Colorado Society Of Anesthesiologists Disagrees With NPATCH's Support To Allow Nurses To Administer Anesthesia Without The Supervision Of A Physician Sat, 04 Sep 2010
"The Colorado Society of Anesthesiologists (CSA) strongly disagrees with NPATCH's support for allowing nurses to administer anesthesia without physician supervision. Regrettably, their action was not unexpected. It is disturbing that NPATCH and others would support policies whereby a patient's life-and-death medical decisions would be made by nurses, not doctors...
Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada Fri, 03 Sep 2010
Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada...
Allergan Resolves United States Government Investigation Of Past Sales And Marketing Practices Relating To Certain Therapeutic Uses Of BOTOX(R) Fri, 03 Sep 2010
Allergan, Inc. (NYSE: AGN) announced that it has reached a resolution with the United States Department of Justice (DOJ) regarding the previously reported Government investigation into Allergan's past U.S. sales and marketing practices relating to certain therapeutic uses of BOTOX® (onabotulinumtoxinA)...
Afferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain Fri, 03 Sep 2010
Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecules that target P2X3 receptors, announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist significantly prevented and reversed bone cancer pain behavior in comparison to vehicle controls...
The Face Of An Infant's Suffering; Can It Be Sugarcoated? Thu, 02 Sep 2010
When your newborn infant is crying with uncomfortable teething or otherwise obviously suffering, feeding sugar to the little one has been a home remedy for years based on not only perceived behavior, but also physiological reactions. However, a new article by Dr...
QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDuo®IR Thu, 02 Sep 2010
QRxPharma (ASX: QRX and OTCQX: QRXPY) announced a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140 patients has greater than 90% power to detect differences of analgesic effect, indicating there is no need to enrol additional patients...
Floridians Prepare To Take Back The State Thu, 02 Sep 2010
September's National Pain Awareness Month has never been more important for the state of Florida. Recent data from the Florida Medical Examiner shows residents are dying at a rate of at least 7 per day as a result of prescription drug abuse...
Surgery To Repair Torn Shoulder Muscles In The Elderly Can Reduce Pain And Improve Function Thu, 02 Sep 2010
Repairing torn shoulder muscles in elderly patients is often discouraged because of fears of complications. But a new study conducted at Rush University Medical Center has shown that minimally invasive, or arthroscopic, surgery can significantly improve pain and function...
BEMA Buprenorphine Phase 2 Study Results Selected For Presentation At Pain Week 2010 Wed, 01 Sep 2010
BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced today that its abstract showing the results of a Phase 2 clinical study of BEMA Buprenorphine in the treatment of pain has been selected for oral presentation at Pain Week 2010, a national conference educating frontline clinicians who are faced with treating patients with pain...
After Needle Accidents, Hospitals Face Legal Dilemma If They Test Incapacitated Patients Wed, 01 Sep 2010
Anaesthetists are calling for greater clarity on the legal implications of testing incapacitated patients for blood-borne viruses, after a survey found that this is often done following staff needlestick injuries, in possible breach of UK legislation...
QRxPharma To Sponsor Symposium At 13th World Congress On Pain Meeting Wed, 01 Sep 2010
QRxPharma (ASX: QRX and OTCQX: QRXPY) announced it will sponsor a symposium at the 13th World Congress of Pain on 31 August, 2010 at Palais des congres de Montreal. The symposium, titled "Dual Opioid Therapy: Changing the Paradigm" will focus on preclinical and clinical data for MoxDuo®IR, an immediate-release Dual Opioid product for moderate to severe acute pain...
Glenmark Announces The Discovery Of A Novel Chemical Entity 'GRC 17536', A TRPA1 Receptor Antagonist, A Potential First-in-Class Molecule Globally Wed, 01 Sep 2010
Glenmark Pharmaceuticals announced the discovery of a Novel Chemical Entity(NCE) 'GRC 17536'. The new NCE program is targeting TRPA1 receptor antagonists for pain and respiratory disorders...
MonoSol Rx Announces Reckitt Benckiser FDA Approval Of Suboxone® Sublingual Film For Treatment Of Opioid Dependence Wed, 01 Sep 2010
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of Reckitt Benckiser Group plc (LSE: RB), has received approval from the U.S...
"Pill Mill" Bill Requires State Certification By Sept. 1 Wed, 01 Sep 2010
Texans seeking pain relief soon can take comfort from a new state law requiring pain management clinics to be certified by the Texas Medical Board (TMB) by Sept. 1. Texas physicians hope the new law will put "pill mills," storefronts disguised as pain medicine clinics, out of commission...
Smoking Cannabis Reduces Pain, Helps Sleep And Improves Mood For Those With Chronic Symptoms Mon, 30 Aug 2010
For patients with chronic (long-term) neuropathic pain, smoking cannabis was found to reduce symptoms of pain, improve mood and help sleep, a report published in CMAJ (Canadian Medical Journal Association) revealed...
Hospira Japan Receives Approval For New Indication For 'Precedex IV(TM) 200ug' Mon, 30 Aug 2010
Hospira Japan Co., Ltd. announced it has received an approval for the long-term (greater than 24 hour) use of the sedative "Precedex IV(TM)200ug" (generic name: dexmedetomidine hydrochloride). This approval follows Hospira's first launches earlier this year of Precedex in Canada and in South Korea, important milestones for Hospira as the company continues to build the molecule's global presence...
Copyright © 1998-2006 Silver Oak Search Consultants, Inc. All Rights Reserved.